Abstract:ASD (Autism Spectrum Disorders) are NDDs (Neurodevelopmental Disorders) with complex etiology including multiple genetic and environmental factors.Non-coding mutations contribute to the multifactorial etiology of ASD by influencing gene activity through various regulatory mechanisms. Advances in genomic technologies, such as whole-genome sequencing (WGS) and chromatin interaction studies, have highlighted the role of non-coding regions in ASD genetics.Identifying these non-coding variants enhances our understanding of the underlying complex genetic landscape ASD. This study aims to analyze the impact of non-coding mutations within regulatory regions in Autism Spectrum Disorder (ASD). The research builds upon a cohort of 360 Spanish ASD trios, from which 200 trios were selected after excluding cases with known copy number variants (CNVs) and whole-exome sequencing (WES) mutations. The selection process intentionally enhanced the sample for undiscovered non-coding risk variants by excluding cases with de novo loss-of-function mutations or large de novo CNVs. To identify regulatory regions of interest, the study employed targeting sequencing of a selection of candidate cis-regulatory elements (cCREs) from ENCODE v2. De novo variation and rare inherited variation were studied using different bioinformatic pipelines and their impact on regulatory activities was assessed using a deep-learning approach (Sei framework). Additional analysis including candidate gene elucidation using ATAC-seq and PLAC-seq data in neuronal cells, variant prioritization, protein-protein interaction (PPI) network,Transcription Factor (TF) enrichment, presence in topologically associated domains (TADs) were also carried out. Sex bias in regulatory variation within ASD was also explored in our analysis.We discovered that 28% of de novo variants and 25% of inherited variants with high regulatory potential were found in patients with negative results from whole-exome sequencing (WES) and microarray analyses, as assessed by Sei. By integrating PLAC-Seq data, we functionally annotated approximately 80% of de novo variants and 85% of inherited variants. While resources like ENCODE provide valuable insights into genomic regulatory elements, it is crucial to be cautious when prioritizing specific regulatory elements based on initial hypotheses regarding their impact on gene regulation: many sequence classes associated with ASD in this study did not show significant enrichment in any particular cCRE signature. Notably, the most important observation in this study is the implication of a global dysregulation of CTCF suggesting a potential mechanistic impact on the chromatin architecture. In addition,We have found that the most high-impact regulatory variants-whether de novo or inherited-are linked to genes not previously associated with ASD. Nevertheless, gene ontology (GO) enrichments indicate that both coding and non-coding variations likely interact within already characterized ASD pathways.

ENCODE guided WGS analysis can identify trait associated regulatory regions driven by rare-variants

Functional Interrogation Of Enhancer Connectome Prioritizes Candidate Target Genes At Ovarian Cancer Susceptibility Loci

Escan: Scan Regulatory Regions for Aggregate Association Testing Using Whole Genome Sequencing Data

A New Approach for Discovering Functional Links Connecting Non-Coding Regulatory Variants to Gene Targets

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Genome-wide enhancer maps link risk variants to disease genes

Deciphering cis-regulatory elements using REgulamentary

Understanding the Function of Regulatory DNA Interactions in the Interpretation of Non-Coding GWAS Variants

Multi-omics analysis in human retina uncovers ultraconserved cis-regulatory elements at rare eye disease loci

DNA-binding factor footprints and enhancer RNAs identify functional non-coding genetic variants

-eQTL mapping in gene sets identifies network effects of genetic variants

Inferring causal cell types of human diseases and risk variants from candidate regulatory elements

Identifying associations of noncoding variants with autism through integration of gene expression, sequence and sex information

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

CWAS-Plus: Estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data

Integrative modeling of eQTLs and cis-regulatory elements suggest mechanisms underlying cell type specificity of eQTLs

Re-Annotation of Presumed Noncoding Disease/Trait-Associated Genetic Variants by Integrative Analyses

Identification, Design, and Application of Noncoding Cis-Regulatory Elements

Leveraging gene co-regulation to identify gene sets enriched for disease heritability

Deciphering the Non-Coding Genome in Autism Spectrum Disorders (ASD): A Study of De Novo and Rare Inherited Variants through Targeted Sequencing in Regulatory Regions